论文部分内容阅读
背景:在中低收入国家中,患者及其家庭有关耐多药肺结核(MDR-TB)费用的公开信息非常少。方法:在2007年2月到7月期间,对细菌学检查确诊并已接受2个月治疗的活动性结核病患者,完成一份有关直接现金支出和工资损失间接费用的面谈问卷。临床信息摘自于医疗记录。结果:104例非MDR-TB患者中,结核病相关的患者总费用平均为960美元/例,相应地,14例参与的MDR-TB患者总费用平均为6880美元,分别占厄瓜多尔年人均收入的31%和223%。MDR-TB相关的高额费用主要是由于较长的病程所致,到访谈时为止,病程平均为22个月。这也导致一段长时间的失业。大多数患者都经历了收入的大幅下降,尤其是MDR-TB患者,在访谈期间,这些人每个月的收入低于100美元。结论:在厄瓜多尔,活动性肺结核患者及其家庭所承受的直接与间接费用是非常高的,其中MDR-TB患者所承受的费用最高。这些费用也是完成治疗的重要障碍。
Background. In low- and middle-income countries, there is very little public information about the costs of MDR-TB in patients and their families. METHODS: Between February and July 2007, an active questionnaire on direct cash and salary costs was completed for patients with active tuberculosis diagnosed bacteriologically and treated for 2 months. Clinical information is taken from medical records. RESULTS: Of 104 non-MDR-TB patients, the average total cost of tuberculosis-related patients was US $ 960 per case. Correspondingly, the total cost of 14 participating MDR-TB patients averaged US $ 6,880, accounting for 31 per cent of Ecuadorian per capita income % And 223%. The high cost associated with MDR-TB was mainly due to a longer duration of disease, with an average duration of 22 months until the interview. It also led to a long period of unemployment. Most patients have experienced a substantial drop in their income, especially in MDR-TB patients, who earn less than $ 100 a month during the interview. Conclusion: In Ecuador, direct and indirect costs incurred by patients with active tuberculosis and their families are very high, with MDR-TB patients being the most expensive. These costs are also important obstacles to completing treatment.